SCHEMBL19859554

SCHEMBL19859554

Cc1ccc(S(=O)(=O)n2cc([C@@H](N[S@+]([O-])C(C)(C)C)C(C)C)cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 4/20 0.40
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 4/20 0.33
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
USP2 O75604 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19859548 1.00 GRM4 (0.40) GRM4LMNAGAAMEN1KMT2A
SCHEMBL19859550 1.00 GRM4 (0.40) GRM4LMNAGAAMEN1KMT2A
SCHEMBL568704 0.83 GRM4 (0.39) GRM4LMNAGAAMEN1KMT2A
SCHEMBL9285181 0.83 GRM4 (0.39) GRM4LMNAGAAMEN1KMT2A
SCHEMBL19859826 0.77 ALDH1A1 (0.40) LMNAGAAMEN1KMT2AALDH1A1
SCHEMBL21047091 0.77 ALDH1A1 (0.40) GRM4LMNAGAAMEN1KMT2A
SCHEMBL21047088 0.77 ALDH1A1 (0.40) GRM4LMNAGAAMEN1KMT2A
SCHEMBL19859825 0.77 ALDH1A1 (0.40) LMNAGAAMEN1KMT2AALDH1A1
SCHEMBL21047093 0.77 ALDH1A1 (0.40) GRM4LMNAGAAMEN1KMT2A
SCHEMBL19859827 0.77 ALDH1A1 (0.40) LMNAGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3497098-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME Zafgen, Inc. (US) 2019-06-19 EP disclosed
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. 2019-06-06 US disclosed
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. 2019-06-06 US disclosed
WO-2018031877-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. (US) 2018-02-15 WO disclosed
WO-2018031877-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. (US) 2018-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME METAP2, DNPEP, FOLH1 GRM4 1644/4885LMNA 3050/4885GAA 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.